Patient Education Blog

Posts Tagged ‘prothrombin 20210 mutation’

Testing for Clotting Disorders – Can It Be Done While on Blood Thinners?

| Acquired risk factors, Antiphospholipid antibodies, Antithrombin deficiency, APC resistance, Clotting disorder - thrombophilia, Factor V Leiden, Inherited (genetic), Protein C deficiency, Protein S deficiency, Prothrombin 20210 mutation | Comments Off on Testing for Clotting Disorders – Can It Be Done While on Blood Thinners?

Stephan Moll, MD writes…  The decision how long to treat a patient who has had a DVT or PE with blood thinners can often be made based just on the patient’s history. Often no testing for clotting disorders (thrombophilias) is needed.  The decision how long to treat is influenced by 3 factors: (1) What is the person’s risk of another clot if he/she is not on blood thinners any more? (2) What is the person’s risk for bleeding on blood thinners? (3) What is the person’s own preference regarding his/her treatment. These issues are discussed in detail here.

However, if one were to do testing, what is the  right time to test? It is important to know that some blood thinners can influence test results.

Read the rest of this entry »

Thrombophilia and Insurance

| Clotting disorder - thrombophilia, Inherited (genetic), Psychological and social consequences of blood clots, Thrombophilia lab tests | 4 Comments »

Liz Varga, Certified Genetic Counselor, Nationwide Children’s Hospital, Columbus OH writes….

Some people may have concerns about genetic testing for clotting disorders (thrombophilias) for fear of genetic discrimination.  Fortunately in the United States, we have laws in place that can alleviate this concern. Read the rest of this entry »